Experienced Sr. Scientist II with a robust background in target discovery platforms, encompassing small molecules, next-generation antibody platform development, CRISPR screening and shRNA/RNAi profiling.
Recognized project manager and leader in diverse internal and external projects, specializing in autoimmune disease areas such as Hidradenitis Suppurativa, Rheumatoid arthritis, SLE, and Atopic Dermatitis.
Proficient in executing next-generation sequencing methods including Bulk RNA-Seq, scRNA-Seq, Oink, TCR BCR Sequencing and Spatial Transcriptomics for advanced immunology discovery programs.
Adept collaborator and communicator, fostering effective teamwork both internally and externally.
Overview
14
14
years of professional experience
Work History
Sr. Scientist II Transformational & Translational
AbbVie
08.2021 - Current
Lead and executing Bulk RNA-Seq, scRNA-Seq and Spatial workflows, managing tasks from tissue storage and sample preparation to data generation specializing in autoimmune disease area.
Support the pathology group in advancing the growth of single-cell spatial multiomic technology in drug development by participating in the development, execution, validation, and troubleshooting of single-cell and spatial multiomic assays for autoimmune diseases.
Collaborating in automated workflow design and execute experimentation for instrument selection or refinement/improvement of sample processes.
Managing portfolio disease projects focusing on disease area Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) ensure each project aligns with overarching goals and objectives.
Support the design and execution of proof-of-concept experiments to initiate portfolio entry for new therapy programs.
Work with clinical team to design sample collection kits, laboratory manual, and specimen logistics for shipments to third party vendors.
Coordinated with multiple teams and managed CROs in a highly matrixed environment.
Mentor and coach team members to help achieve the project goals.
Scientist Project Lead
Skyhawk Therapeutics
05.2019 - 08.2020
Development and of current and new protocols on a variety of sample types such as whole blood, FFPE tissue samples and plasma. (bulk RNA-Seq, Drug-Seq, scRNA-Seq, Smart-Seq, Drug-Seq, CITE-Seq, and long-read sequencing Nanopore sequencing platform).
Tested and validated a low-cost and HTS NGS based (3’UPX kit) to proof-of-concept screening for novel compound mechanistic studies and compound repurposing efforts.
Designed and Developed PCR-based assays for quantifying gene expression.
Serve as a knowledgeable resource for variety single-cell technology, provide guidance on experimental design, method or platform selection.
Utilize available resources to achieve timely execution of projects and collaborate with cross-functional teams (internal and external) to execute plans and deliverables.
Provided scientific and operational oversight of CROs and other ancillary vendors.
Educate other associate scientists, provide hands-on training, and give internal and external presentations.
Research Scientist Sequencing Core
Boston University
12.2017 - 05.2019
Developed, validated and troubleshooted on bulk RNA-Seq, scRNA-Seq (such as Smart-Seq, Cel-Seq,10X Genomic) on difficult clinical specimen.
Developed and optimized new tissue dissociation, immune cell purification and PBMC isolation protocols to expanded services by the scRNA-Seq core.
Coordinated and led research projects for clinical samples screen, Illumina platform, and scRNA-Seq for therapeutic discovery.
Successfully completed over 50 academic and industrial client’s projects for over 1000 samples from BUMC, BU and pharmaceutical companies.
Research Scientist
Pfizer
07.2016 - 05.2017
Developed and improved protocols for human iPSC/ESC to cardiomyocyte, hepatocytes and neuron cells.
Reprogrammed human skin fibroblasts and hematopoietic stem cells by retroviral methods into iPSC stem cells.
Gene expression profiling experimental design, RNA isolation and QC, differential gene expression analysis follow up validation with qPCR and providing biomarkers and MOA based on expression and pathway analysis.
Optimized transfection conditions for genome-editing tools such as CRISPR and siRNA overexpression construct delivery.
Developed multiplexed phenotypic assays for cellular and drug target biology utilizing chemical genomics, RNAi, lentivirus, CRISPR, and overexpression platforms.
Postdoctoral Fellow
University of Connecticut
05.2013 - 03.2016
Developed animal models to predict variation of drugs response and Drug-Drug interaction.
Differentiation of human Cardiac iPSCs for Drug Screening & Discovery.
Next generation RNA sequencing samples QC, library preparation, data analysis.
Phenotypic Screens in 96-well format to identify and validate targets for CVD using physiologically relevant cell models (differentiated cell lines, stem cells, primary cells).
Collaborated with PI and colleague to conceptualize, edit, and contribute data to an NIH R01 grant.
Postdoctoral Research Fellow
Yale University Department of Pharmacology
07.2011 - 08.2012
Dose- response expression profiling for MOA study of compound efficacy, toxicity, and off-target activity in tissue culture.
Compound profiling and mechanism of actions studies for therapeutic molecules against a broad range of molecular targets, including enzymes kinetics and GPCRs.
Established international collaboration with leading labs to test "actives" from a screen of 10K compounds and identified compounds for further testing in preclinical trials
Phase II study of PHY906 combining CPT-11 in advanced hepatocellular carcinoma.
Education
Ph.D. - Pharmacology
China Medical University
Taiwan
07-2012
Skills
Single-Cell and RNA Sequencing
Proficient in single-cell and single-nucleus isolation from tissue and blood from clinical trial
Skilled in different library preparation using 10x Genomics Chromium and other single-cell platforms
Project Management
Accomplishments
AbbVie VP Award 2022
James R. Gillette Best Paper Award. The 1st place award for Postdoctoral Fellow
Travel award for The American for Pharmacology and Experimental Therapeutics
First Place award from The American association for Pharmacology
Graduate Study Abroad Program provided by the National Science Council.
Departmental Honors for Senior Thesis provided by the College of Pharmacy, Taiwan.
First Place award for Pharmacology PhD students, Taiwan